Treatment of adult-onset Still's disease: a review


Autoria(s): Jamilloux Y.; Gerfaud-Valentin M.; Henry T.; Seve P.
Data(s)

2015

Resumo

Adult-onset Still's disease (AOSD) is a rare inflammatory disorder that has been recently classified as a polygenic autoinflammatory disorder. The former classification, based on the disease course, seems to be quite dated. Indeed, there is accumulating evidence that AOSD can be divided into two distinct phenotypes based on cytokine profile, clinical presentation, and outcome, ie, a "systemic" pattern and an "articular" pattern. The first part of this review deals with the treatments that are currently available for AOSD. We then present the different strategies based on the characteristics of the disease according to clinical presentation. To do so, we focus on the two subsets of the disease. Finally, we discuss the management of life-threatening complications of AOSD, along with the therapeutic options during pregnancy.

Identificador

http://serval.unil.ch/?id=serval:BIB_C8BCB433233B

isbn:1178-203X

doi:10.2147/TCRM.S64951

isiid:000346662900003

Idioma(s)

en

Fonte

Therapeutics and Clinical Risk Management, vol. 110, pp. 33-43

Palavras-Chave #adult-onset Still's disease; treatment; anakinra; tocilizumab; canakinumab
Tipo

info:eu-repo/semantics/review

article